Aspirin Activates Resolution Pathways to Reprogram T Cell and Macrophage Responses in Colitis-Associated Colorectal Cancer

The authors demonstrated that aspirin increased concentrations of the immune-regulatory aspirin-triggered (AT) specialized proresolving mediators, including AT-lipoxin A₄ and AT-resolvin D1, in colonic tissues during inflammation-associated colorectal cancer.